AGL
HealthcareAgilon Health, Inc. · Medical - Care Facilities · $1B
What is Agilon Health, Inc.?
Agilon Health is a healthcare services company focused on delivering primary care to seniors across the United States. It partners with community-based physicians to serve Medicare Advantage and fee-for-service beneficiaries.
Agilon Health works alongside primary care physicians to coordinate and manage healthcare for senior patients. Its model centers on value-based care — aligning physician incentives with patient outcomes rather than visit volume. The company primarily serves Medicare Advantage members and Medicare fee-for-service beneficiaries, acting as an enablement platform that helps independent physicians take on financial and clinical responsibility for their senior patient panels.
Agilon health, inc. was founded in 2016 and is headquartered in Austin, Texas.
- Value-based primary care enablement for senior patients
- Medicare Advantage population health management
- Medicare fee-for-service care coordination
- Physician partnership and risk-sharing model
Is AGL a Good Stock to Buy?
UQS Score rates AGL as Poor overall, placing it in the lowest tier of scored equities.
Among the five pillars, Risk is the lone area registering a Neutral reading, suggesting the company's balance sheet or near-term financial exposure is not at the most extreme end of concern relative to peers.
Quality, Moat, Growth, and Valuation all carry Weak or Elevated ratings — a broad-based weakness that signals limited competitive differentiation, constrained earnings quality, and a valuation that does not appear to reflect the underlying fundamentals.
Pro members can view the complete pillar breakdown and underlying financial metrics to understand exactly where AGL stands. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does AGL pay dividends?
No — Agilon Health, Inc. does not currently pay a dividend.
Agilon Health does not currently pay a dividend. As a growth-oriented healthcare services company still working toward consistent profitability, capital is directed toward expanding its physician partnership network and scaling its value-based care platform rather than returning cash to shareholders.
When does AGL report earnings?
Agilon Health reports earnings on a quarterly cadence, consistent with standard practice for US-listed equities.
The company's recent results have reflected the challenges of scaling a value-based care model — membership growth has been a focus, but profitability has remained elusive as medical costs and operational expenses weigh on margins. Investors have closely watched membership trends and medical cost ratios as key indicators of business health.
For the most recent quarter's results and guidance updates, visit Agilon Health's investor relations page directly.
AGL Price History
-97.3% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Agilon Health, Inc.?
Based on Agilon Health, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
AGL Long-term Outlook
The UQS Growth pillar for AGL carries a Weak label, reflecting limited evidence of durable, high-quality expansion in the near term. The Elevated Valuation pillar adds further caution — the stock's current pricing does not appear well-supported by the underlying fundamentals. While the value-based care sector carries long-term structural tailwinds from an aging US population, AGL's path to sustainable profitability remains a central question for long-term holders.
Growth drivers
- Aging US population increasing demand for senior-focused primary care
- Expansion of Medicare Advantage enrollment nationally
- Potential to deepen physician partnerships in existing and new markets
Key risks
- Persistently elevated medical costs compressing margins
- Valuation rated Elevated relative to current earnings profile
- Competitive pressure from larger, better-capitalized healthcare networks
AGL vs Peers
Agilon Health operates in a competitive healthcare services landscape alongside companies serving senior and community health markets.
Community Health Systems operates a broad network of acute-care hospitals, giving it a very different revenue profile and scale compared to Agilon's physician-enablement model.
Auna focuses on oncology and healthcare services in Latin America, representing a geographically distinct approach to managed and specialty care.
Sonida Senior Living provides residential senior care communities, competing for the senior healthcare dollar through a facility-based model rather than primary care coordination.
Frequently Asked Questions
What does Agilon Health do?
Agilon Health partners with community-based primary care physicians to manage healthcare for senior patients. Its platform enables physicians to participate in value-based care arrangements, primarily serving Medicare Advantage and Medicare fee-for-service members across the United States.
Does AGL pay dividends?
No, Agilon Health does not pay a dividend. The company is focused on scaling its physician partnership network and has not reached the level of consistent profitability typically associated with dividend-paying healthcare companies.
When does AGL report earnings?
Agilon Health follows a standard quarterly earnings schedule. Specific dates are not covered by our data source — check the company's investor relations page for the most current reporting calendar.
Is AGL a good stock to buy?
The UQS Score rates AGL as Poor, reflecting weakness across Quality, Moat, Growth, and an Elevated Valuation. That combination warrants careful scrutiny. Pro members can access the full pillar breakdown to weigh the details before making any decision.
Is AGL overvalued?
The UQS Valuation pillar for AGL is rated Elevated, suggesting the current market price is not well-supported by the company's underlying earnings profile. This is a meaningful consideration given the Weak ratings across other pillars.
How does AGL compare to its competitors?
Compared to peers like Community Health Systems, Auna, and Sonida Senior Living, Agilon operates a distinct physician-enablement model rather than owning facilities or hospitals. Each competitor serves the senior or community health market through a different structural approach.
What is AGL's market cap bracket?
Agilon Health is classified as a small-cap company. This places it in a segment of the market that can carry higher volatility and liquidity risk compared to large- or mega-cap healthcare peers.
Who founded Agilon Health?
Agilon Health was originally established under the name Agilon Health Topco, Inc. and rebranded to its current name in March 2021. Founding details are widely available through the company's public filings and investor relations materials.
Is AGL a long-term quality investment?
As a long-term quality indicator, the UQS Score rates AGL as Poor. Weak readings across Quality, Moat, and Growth suggest the company has not yet demonstrated the durable competitive advantages typically associated with high-quality long-term holdings. The full analysis is available to Pro members.
What is the main competitive advantage of Agilon Health?
Agilon's model centers on enabling independent physicians to participate in value-based care without bearing the full administrative burden alone. However, the UQS Moat pillar rates this advantage as Weak, indicating limited evidence of durable differentiation relative to the broader healthcare sector.
What sector does AGL belong to?
Agilon Health operates in the Healthcare sector, specifically within the value-based primary care and managed care space. It focuses exclusively on senior patients through Medicare-aligned programs, making it a niche player within a large and competitive industry.
Is AGL a growth stock or value stock?
Based on UQS pillar labels, AGL does not fit neatly into either category. The Growth pillar is rated Weak, and the Valuation pillar is rated Elevated — a combination that suggests neither strong growth momentum nor an attractive entry price relative to fundamentals.
Unlock Full AGL Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View exact UQS pillar scores across all five dimensions
- ✓Access underlying financial metrics driving each rating
- ✓Compare AGL against sector peers side by side
- ✓See the complete risk and valuation breakdown
- ✓Track score changes as new earnings data arrives
Pro Analysis
AGL — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | 17.8 | 0.0 | 20.0 | 24.8 | 52.1 | 0.0 | +0.2 |
| May 21, 2026 | 17.6 | 0.0 | 20.0 | 23.9 | 52.1 | 0.0 | +0.2 |
| May 17, 2026 | 17.4 | 0.0 | 20.0 | 22.9 | 52.1 | 0.0 | -0.9 |
| May 12, 2026 | 18.3 | 0.0 | 20.0 | 27.3 | 52.1 | 0.0 | -0.2 |
| May 10, 2026 | 18.5 | 0.0 | 20.0 | 27.3 | 53.9 | 0.0 | 0.0 |
| May 9, 2026 | 18.5 | 0.0 | 20.0 | 27.3 | 53.8 | 0.0 | +0.1 |
| May 8, 2026 | 18.4 | 0.0 | 20.0 | 26.7 | 53.8 | 0.0 | +0.1 |
| Apr 10, 2026 | 18.3 | 0.0 | 20.0 | 26.6 | 53.2 | 0.0 | 0.0 |
| Apr 2, 2026 | 18.3 | 0.0 | 20.0 | 26.8 | 53.2 | 0.0 | — |
AGL — Pillar Breakdown
Quality
— 0.0/100 (25%)Agilon Health, Inc. currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Free cash flow relative to market value.
Growth
— 24.8/100 (20%)Agilon Health, Inc. faces growth headwinds with declining or stagnant revenue trends.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Risk
— 52.1/100 (15%)Agilon Health, Inc. has some risk factors including moderate leverage or solvency concerns.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 0.0/100 (15%)Agilon Health, Inc. appears expensively valued relative to its fundamentals and growth prospects.
Moat
— 20/100 (25%)Agilon Health, Inc. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for AGL.
Score Composition
Financial Data
More Stock Analysis
How is the AGL UQS Score Calculated?
The UQS (Unified Quality Score) for Agilon Health, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Agilon Health, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Agilon Health, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.